EBS - Emergent BioSolutions Inc.
Close
8.1
-0.020 -0.247%
Share volume: 7,745
Last Updated: Fri 27 Dec 2024 05:29:46 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.39%
PREVIOUS CLOSE
CHG
CHG%
$8.12
-0.02
-0.25%
Summary score
16%
Profitability
2%
Dept financing
18%
Liquidity
17%
Performance
29%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-4.03%
Return on assets
1.14%
Return on sales
-0.16%
Return on invested capital
-7.08%
Total debt ratio
52.54%
Debt ratio change over timeo
-1.43%
Current Ratio
2.53%
Quick Ratio
1.63%
Cash Position Ratio
0.91%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-17.97%
Return on assets
-0.2%
Return on sales
-1.8%
Return on invested capital
-24.41%
Total debt ratio
61.71%
Debt ratio change over timeo
5.62%
Current Ratio
1.08%
Quick Ratio
0.56%
Cash Position Ratio
0.14%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
1.36%
Return on assets
2.21%
Return on sales
13.25%
Return on invested capital
1.83%
Total debt ratio
63.19%
Debt ratio change over time
-6.89%
Current Ratio
1.08%
Quick Ratio
0.55%
Cash Position Ratio
0.12%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-44.15%
Return on assets
-66.08%
Return on sales
144.88%
Return on invested capital
-40.43%
Total debt ratio
-143.18%
Debt ratio change over time
-1.43%
Current Ratio
-52.27%
Quick Ratio
-30.6%
Cash Position Ratio
-20.55%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | EBS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -4.03% | 13.79% | 34.47% | 7.43% |
| Return on assets | 1.14% | 2.76% | 3.15% | 5.62% |
| Return on sales | -0.16% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -7.08% | 2.36% | 5.39% | 19.77% |
| Profitability | 5% | 43% | 66% | 80% |
| Total debt ratio | 52.54% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.43% | 308.97% | -6.99% | 1.18% |
| Dept financing | 15% | 50% | 25% | 7% |
| Current Ratio | 1.08% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 0.56% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 0.14% | 0.36% | 1.28% | 2.93% |
| Liquididy | 36% | 14% | 33% | 75% |
| Short-term ratios | EBS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -17.97% | 13.77% | 13.25% | 3.8% |
| Return on assets | -0.2% | 2.43% | 1.89% | 3.09% |
| Return on sales | -1.8% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -24.41% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 61.71% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | 5.62% | 46.38% | -72.08% | 1.51% |
| Dept financing | 20% | 50% | 25% | 7% |
| Current Ratio | 1.08% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 0.56% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 0.14% | 0.36% | 1.28% | 2.93% |
| Liquididy | 9% | 12% | 31% | 75% |